Author Behrens, Georg M. N.
-
2019 | Journal Article | Research Paper |
Pediatric Healthcare Utilization in a Large Cohort of Refugee Children Entering Western Europe During the Migrant Crisis
Happle, C.; Dopfer, C.; Ernst, D. ; Kleinert, E. ; Vakilzadeh, A.; Hellms, S. & Evlampidou, I. et al. (2019)
International Journal of Environmental Research and Public Health, 16(22) pp. 4415. DOI: https://doi.org/10.3390/ijerph16224415
Details DOI
-
2020 | Journal Article |
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
Bošnjak, B.; Stein, S. C.; Willenzon, S.; Cordes, A. K.; Puppe, W.; Bernhardt, G. & Ravens, I. et al. (2020)
Cellular & Molecular Immunology, 18(4) pp. 936-944. DOI: https://doi.org/10.1038/s41423-020-00573-9
Details DOI
-
2021 | Journal Article |
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Barros-Martins, J.; Hammerschmidt, S. I.; Cossmann, A.; Odak, I.; Stankov, M. V.; Morillas Ramos, G. & Dopfer-Jablonka, A. et al. (2021)
Nature Medicine,. DOI: https://doi.org/10.1038/s41591-021-01449-9
Details DOI
-
2021 | Journal Article |
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
Hammerschmidt, S. I.; Bosnjak, B.; Bernhardt, G.; Friedrichsen, M.; Ravens, I.; Dopfer-Jablonka, A. & Hoffmann, M. et al. (2021)
Cellular & Molecular Immunology, 18(10) pp. 2455-2456. DOI: https://doi.org/10.1038/s41423-021-00755-z
Details DOI
-
2021 | Journal Article |
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Sidarovich, A.; Winkler, M. S. & Schulz, S. et al. (2021)
Cellular & Molecular Immunology, 18(11) pp. 2557-2559. DOI: https://doi.org/10.1038/s41423-021-00772-y
Details DOI
-
2021 | Journal Article |
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
Arora, P.; Rocha, C.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S. & Lier, M. et al. (2021)
Cellular & Molecular Immunology, 18(12) pp. 2673-2675. DOI: https://doi.org/10.1038/s41423-021-00779-5
Details DOI
-
2022 | Journal Article |
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Schulz, S.; Cossmann, A. & Dopfer-Jablonka, A. et al. (2022)
Cellular & Molecular Immunology,. DOI: https://doi.org/10.1038/s41423-022-00870-5
Details DOI
-
2022 | Journal Article |
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
Behrens, G. M. N.; Barros-Martins, J.; Cossmann, A.; Ramos, G. M.; Stankov, M. V.; Odak, I. & Dopfer-Jablonka, A. et al. (2022)
Nature Communications, 13(1). DOI: https://doi.org/10.1038/s41467-022-32527-2
Details DOI
-
2022 | Journal Article | Research Paper |
Immunogenicity of COVID-19 vaccination in melanoma patients under immune checkpoint blockade
Niewolik, J.; Mikuteit, M.; Cossmann, A.; Vahldiek, K.; Gutzmer, R.; Müller, F. & Schröder, D. et al. (2022)
Oncology,. DOI: https://doi.org/10.1159/000524894
Details DOI
-
2022 | Journal Article | Research Paper
SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study
Dopfer-Jablonka, A.; Steffens, S.; Müller, F. ; Mikuteit, M.; Niewolik, J.; Cossmann, A. & Stankov, M. V. et al. (2022)
BMC Infectious Diseases, 22(1) art. 403. DOI: https://doi.org/10.1186/s12879-022-07347-w
Details DOI PMID PMC